drugset / Trial / NCT02171572
Single and Multiple Oral Doses of Dabigatran Etexilate in Healthy Chinese Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of the current study is to investigate safety, tolerability and, pharmacokinetics of dabigatran etexilate following oral administration of single and multiple oral doses (110mg, 150 mg b.i.d., 7 days) in healthy Chinese subjects.
Timeline
- Start
- 2009-10
- Primary completion
- 2009-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran etexilate | Unknown | 110 mg | Oral |
| Subject | Dabigatran etexilate | Unknown | 150 mg | Oral |
Indications
No indication recorded.